Join Our Newsletter
|
Contact
|
Glossary
Facebook
Twitter
Linkedin
MENU
MENU
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
SLIHCQ Database
Overview
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
Overview
SLIHCQ Database
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Search
Articles & Reports
Key Issues
All
HEALTHCARE MARKETS
- Provider Network
-- Telehealth or Telemedicine
-- Scope of Practice
-- Any Willing Provider
-- Network Adequacy
-- Tiered Network or Narrow Network
- Competition
-- Antitrust Enforcement
-- Healthcare Consolidation
-- Most Favored Nation (MFN)
-- Certificate of Need (CON)
-- Certificate of Public Advantage (COPA)
-- All-or-Nothing
-- Anti-Steering or Anti-Tiering
-- Non-Compete Provision
-- Price Manipulation
-- Competitive Bidding
-- Trade Secret
- Rate Regulation
- ACA Marketplace
HEALTHCARE COSTS
- Cost Containment
-- Shared Savings or Right to Shop
-- Reference Pricing
-- Prior Authorization
-- Utilization Review
- Price Gouging
- Cost-Sharing or Out-of-Pocket Costs
- High Deductible Health Plan (HDHP)
- Health Savings Account (HSA) or Health Reimbursement Account (HRA)
- Benefit Design
- Provider Payment
-- Value-Based Payment
-- Bundled Payment
-- Global Payment or Global Budget
-- Capitation
-- Population-Based Payment
-- Shared Risk or Risk-Based Payment
-- Facility Fee
HEALTHCARE SYSTEM REFORM
- COVID-19 Crisis
- Single Payer or Multi-Payer
- Public Option
- Delivery Reform
- Quality or Value-Based Reform
- Managed Competition
- Accountable Care Organization (ACO)
- Medicaid Reform or Medicaid Waiver
- Affordable Care Act (ACA)
- Federal Reform Effort
PRICE AND QUALITY TRANSPARENCY
- All-Payer Claims Database (APCD)
- Gag Clause or Non-Disclosure Agreement
- Surprise Billing or Balance Billing
- Quality Measure
PHARMACEUTICALS
- Drug Pricing
- Drug Formulary
- Pharmacy Benefit Manager (PBM)
- Pharmacy Regulation
-- Clawback Restriction
- Biosimilar or Generic Competition
-- Generic Competition Block or Delay
- Therapeutic Substitution
- Medicaid Pharmaceuticals
- Medicare Part D
- 340B Drug Pricing Program
- Drug Importation
Jurisdiction
All
Federal
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Start Date
End Date
Workers Compensation Research Institute
Hospital Outpatient Payment Index: Interstate Variations and Policy Analysis, 10th Edition
May 6, 2021
American Antitrust Institute
AAI Says UnitedHealth Group’s Acquisition of Rival, Change Healthcare, Could Harm Competition: Letter to DOJ Examines Features of Digital Healthcare Technology Markets That Exacerbate Antitrust Concerns
May 5, 2021
JAMA Network
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
May 4, 2021
Kaiser Family Foundation
Health Insurer Financial Performance in 2020
May 3, 2021
Health Affairs
Frequency Of Generic Drug Price Spikes And Impact On Medicaid Spending
May 3, 2021
Health Affairs
Diabetes Drugs: List Price Increases Were Not Always Reflected In Net Price; Impact Of Brand Competition Unclear
May 3, 2021
Health Affairs
Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003–17
May 3, 2021
Health Affairs
Higher Medicare Spending On Imaging And Lab Services After Primary Care Physician Group Vertical Integration
May 3, 2021
Catalyst for Payment Reform
Reference-based Pricing: Risks and Rewards of Playing Health Care Hardball
April 30, 2021
Kaiser Family Foundation
How Corporate Executives View Rising Health Care Cost and the Role of Government
April 29, 2021
Kaiser Family Foundation
Health Spending for 60-64 Year Olds Would Be Lower Under Medicare Than Under Large Employer Plans
April 27, 2021
Kaiser Family Foundation
How Lowering the Medicare Eligibility Age Might Affect Employer-Sponsored Insurance Costs
April 27, 2021
JAMA Network
Frequency and Costs of Out-of-Network Bills for Outpatient Laboratory Services Among Privately Insured Patients
April 26, 2021
Kaiser Family Foundation
Relatively Few Drugs Account for a Large Share of Medicare Prescription Drug Spending
April 19, 2021
Health Affairs Blog
Reversing Hospital Consolidation: The Promise Of Physician-Owned Hospitals
April 19, 2021
NEJM Catalyst
Nonprofit Health Plans Launch Telehealth-First Options to Increase Access and Affordability
April 15, 2021
Next
